Quick Answer
Tectonic Therapeutic, Inc. reported R&D Expense of $63.49 million for fiscal year 2025.
Tectonic Therapeutic, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $63.49M | +53.5% |
| 2024 | $41.36M | +11.9% |
| 2023 | $36.97M | -48.8% |
| 2022 | $72.19M | -13.1% |
| 2021 | $83.11M | -4.7% |
| 2020 | $87.24M | +58.7% |
| 2019 | $54.97M | +56.6% |
| 2018 | $35.09M | +131.0% |
| 2017 | $15.19M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.93M | +18.2% | -1.5% |
| June 30, 2025 | $17.18M | +142.9% | +31.8% |
| March 31, 2025 | $13.04M | +20.5% | -8.9% |
| September 30, 2024 | $14.32M | +76.0% | +102.4% |
| June 30, 2024 | $7.07M | -19.3% | -34.6% |
| March 31, 2024 | $10.82M | -37.6% | +33.0% |
| September 30, 2023 | $8.13M | -48.9% | -7.2% |
| June 30, 2023 | $8.77M | -53.6% | -49.4% |
- Tectonic Therapeutic, Inc. showed an increase of +53.5% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, Tectonic Therapeutic, Inc.’s r&d expense has grown by 317.9% (from $15.19 million to $63.49 million).
- The most recent figure is from Tectonic Therapeutic, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: